Protecting the
medicines that
protect us.
Antimicrobial resistance and emerging infections are unfolding in our hospitals, farms and neighbourhoods today. I work at the intersection of medicine, epidemiology and social science to understand how these threats evolve — and to turn that understanding into action.
Lecturer, Public and Community Health Programs
Dodge Family College of Arts and Sciences
University of Oklahoma
Lead Editor, Springer Nature
BioMed Central journals
01 / About
My questions come from three places — the bedside, the field site, and the policy table.
Practice & field
I trained and practised as a clinician in Kolkata — first in critical care and anaesthesiology, then in preventive and community medicine. Fieldwork has since taken me across India: antibiotic use among caregivers and smallholder dairy farmers in rural West Bengal, enteric fever and cholera surveillance, water and sanitation exposure in urban slums, and zoonotic risk at the peri-urban human–animal–environment interface.
Research & policy
As a scientist at ICMR-NICED I co-led a phase IV rotavirus vaccine trial that supported national scale-up. At ICMR headquarters during COVID-19 I ran the secretariat of India’s National Task Force, contributing rapid evidence synthesis, the PLACID convalescent plasma trial and the first national serosurvey. I drafted background evidence for India’s National Action Plan on AMR and built evaluation instruments now used across WHO SEARO.
PhD
International Health, Epidemiology
Bloomberg School of Public Health, Johns Hopkins University, USA
DTM&H
Royal College of Physicians
London
MD
University College of Medical Sciences
New Delhi
MBBS
Medical College and Hospitals
Kolkata
02 / Research
Research as a bridge between evidence and empathy.
My work brings together medicine, epidemiology and social science to understand how these threats evolve, and to turn that understanding into action.
Defining the Problem
Measuring burden, exposure and vulnerability — from enteric fever and cholera surveillance to zoonoses priority-setting and the health of marginalised urban populations.
02Developing & Testing Solutions
Pairing quantitative rigour with ethnographic insight to test not just whether an intervention works, but why.
03Monitoring & Evaluation
Identifying the levers that let promising pilots scale, adapt and survive contact with real systems.
03 / Selected work
Research that moved policy.
Antimicrobial Use and Interventions in Rural India
A mixed-methods dissertation across three strands: how caregivers seek care and use antibiotics for children; how smallholder farmers access and decide on antibiotics for livestock; and how far rotavirus vaccination reduces antibiotic-treated diarrhoea.
RVICS — Rotavirus Vaccine Interchangeability Trial
A multicentre, open-label, randomised controlled non-inferiority trial testing whether Rotavac and Rotasiil could be given in an interchangeable schedule. The evidence supported national scale-up of India’s rotavirus programme; published in The Lancet Infectious Diseases.
2020
PLACID — Convalescent Plasma in COVID-19
Phase II open-label randomised trial in moderate COVID-19; findings shaped national case-management policy.
Co-Investigator · ICMR2017–2020
National Surveillance System for Enteric Fever
Multi-site surveillance to estimate India’s true enteric fever burden and guide typhoid vaccine policy.
Co-Investigator · CMC Vellore / Gates Foundation2015–2017
AMR Situation-Analysis Tools for WHO
A surveillance-assessment instrument used across SEARO member states, and the India review that fed the National Action Plan on AMR.
Senior Research Associate · PHFI / WHO2015–2017
Peri-Urban Human–Animal–Environment Interface
A national One Health research programme on disease risk where livestock, people and cities meet.
Senior Research Associate · PHFI / IDRC Canada50+
Peer-reviewed papers
~4,000
Citations
7
Policy documents
18
Oral presentations
04 / Research tool
Ask my dissertation
a question.
An evidence-grounded assistant constrained to two sources — my dissertation and its analytic memos. Quantitative results are reproduced verbatim, with citations to section. No speculation, no external browsing.
Open the assistant →What was the estimated effectiveness of rotavirus vaccination against antibiotic-treated diarrhoea?
The assistant answers from the dissertation text and its analytic memos — reproducing point estimates and confidence intervals exactly as reported, naming the model used, and citing the section the result comes from.
Source: Dissertation §4.3
05 / Nonprofit
Protecting antibiotics is not just a scientific goal. It is a moral one.
STOP AMR is a 501(c)(3) nonprofit I helped establish, working with communities to mitigate the impact of antimicrobial resistance through education, advocacy and locally owned action.
Visit stopamr.org →06 / Publications
Selected publications
Safety and immunogenicity of the Rotavac and Rotasiil rotavirus vaccines administered in an interchangeable dosing schedule among healthy Indian infants: a multicentre, open-label, randomised, controlled, phase 4, non-inferiority trial
Kanungo S, Chatterjee P, Bavdekar A, Murhekar M, Babji S, et al.
One Health, “Disease X” & the challenge of “unknown” unknowns
Chatterjee P, Nair P, Chersich M, Terefe Y, Chauhan AS, Quesada F, Simpson G
Going beyond access to health information: a pandemic call to action
Bhaumik S, Chatterjee P
Environmental impacts of mass drug administration programs: exposures, risks, and mitigation of antimicrobial resistance
Konopka JK, Chatterjee P, LaMontagne C, Brown J
Mapping cholera outbreaks and antibiotic resistant Vibrio cholerae in India: an assessment of existing data and a scoping review of the literature
Chatterjee P, Kanungo S, Bhattacharya SK, Dutta S
Water, sanitation, and hygiene practices in urban slums of Eastern India
Kanungo S, Chatterjee P, Saha J, Pan T, Chakrabarty ND, Dutta S
The complete publication record
Peer-reviewed papers, book chapters, consortium publications and conference abstracts.
07 / Teaching & policy